Categories
Nath Bio-Genes (India) Limited — Board Meeting, 04-05-2026: Outcome of Board Meeting
04-05-2026 · 05:10 pm
Nath Bio-Genes' board approved FY26 consolidated results: Net profit ₹41.63 Cr on ₹445.10 Cr revenue. A ₹2/share dividend was proposed. Key appointments also included reappointing Director Hitesh Purohit and raising MD Satish Kagliwal's annual remuneration to ₹1.44 Cr.
No comments yet. Be the first to comment!